Here are 18 key notes on orthopedic and spine device companies over the past week.
Johnson & Johnson's medical device segment plans to launch more than 20 new products in both the clinical and consumer product segments by 2018.
Medtronic and NuVasive lead the U.S. minimally invasive spine fusion market, which is anticipated to surpass $1.15 billion by 2021.
Centinel Spine expanded its STALIF product family in the United States and Australia.
NuVaisve launched AttraX Putty, the newest addition to its biologics portfolio, in the United States.
SeaSpine's revenue totaled $31.4 million in the first quarter of 2016, a 2.8 percent decline compared to the first quarter of 2015.
Zimmer Biomet completed its acquisition of Cayenne Medical.
In a new study, researchers found Providence Medical Technology's DTRAX system reduced NDI, VAS neck pain, VAS arm pain, SF-12 PCS and SF-12 MCS.
Congress of the Chinese Association of Orthopedic Surgeons Meeting featured a presentation on Misonix's BoneScalpel.
Chicago-based Northwestern's vice chairman of orthopedic surgery David Manning, MD, will perform a live total knee replacement surgery using Medacta's integrated knee platform.
Vertebral Technologies launched the InterLink pedicle screw system.
The FDA cleared Interventional Spine's 80 Lumbar Lordotic Opticage Expandable Intervertebral Body Fusion Device.
Ceterix Orthopaedics appointed Edward Graubart its new vice president of sales.
WBZ NewsRadio 1030 featured InVivo Therapeutics on its radio broadcast.
The FDA recently cleared Spinal Balance's No-Touch Pre-Sterilized Pedicle Screw System.
Ortho Kinematics received Health Canada authorization for its Vertebral Motion Analysis.
Implanet's Jazz Claw was granted 510(k) clearance in the United States and the CE Mark in Europe.
Mainstay Medical received CE Mark approval for ReActiv8, its implantable neurostimulation system.
The FDA approved Boston Scientific's Precision Montage Spinal Cord Stimulator.